Article Information
History
- September 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Victor Gravrand1,
- François Mellot2,
- Felix Ackermann3,
- Marie-Christine Ballester4,
- Benjamin Zuber5,
- James T. Kirk6,
- Krupa Navalkar6,
- Thomas D. Yager6,
- Fabien Petit1,
- Tiffany Pascreau1,7,
- Eric Farfour1 and
- Marc Vasse1,7,§
- 1Biology Department, Foch Hospital, Suresnes, France
- 2Radiology Department, Foch Hospital, Suresnes, France
- 3Internal Medicine Department, Foch Hospital, Suresnes, France
- 4Emergency Department, Foch Hospital, Suresnes, France
- 5Intensive Care Unit, Foch Hospital, Suresnes, France
- 6Immunexpress, Inc., Seattle, Washington, United States)
- 7UMR-S1176, Le Kremlin-Bicêtre, France
- ↵§Corresponding author, at email address: m.vasse{at}hopital-foch.com
Posted September 18, 2022.
Stratification of COVID-19 severity using SeptiCyte RAPID, a novel host immune response test
